ASCENDIS HEALTH LIMITED - Dealings in securities by an associate of a director & disclosure of acquisition of securities

Dealings in securities by an associate of a director & disclosure of acquisition of securities

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
("Ascendis Health" or "the Company")


DEALINGS IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR & DISCLOSURE OF ACQUISITION OF SECURITIES


DEALINGS IN SECURITIES BY AN ASSOCIATE

In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the
following information regarding the dealings in securities is disclosed:

Name of director                                   Carl Neethling

Name of company of which the director is a         Ascendis Health Limited
director

Date of transactions                               23 September 2024


Price per security (Cents)                         74


Number of securities                               1 500 000


Total rand value of securities                     R1 110 000.00

Class of securities                                Ordinary shares

Nature of transactions                             Purchase of shares by an associate of the
                                                   director (on-market transactions)

Nature and extent of directors interest in the     Indirect, beneficial
transactions

Name of associate                                  Carl Andre Capital (Pty) Ltd

Relationship with director                         Director is a director of the associate and
                                                   a beneficiary of a trust that is the
                                                   shareholder of the associate

Clearance for the above was obtained in terms of paragraph 3.66 of the JSE Limited Listings
Requirements.

DISCLOSURE OF ACQUISITION OF SECURITIES

In accordance with section 122(3)(b) of the Companies Act No. 71 of 2008, as amended ("Companies
Act") and paragraph 3.83(b) of the JSE Limited Listings Requirements, shareholders are hereby
advised that the Company has received formal notification in the prescribed form from Carl Andre
Capital Proprietary Limited ("Carl Andre Capital"), advising that it has acquired a beneficial interest in                                                                                                        
securities of the Company, such that the total of all beneficial interests held by it amounts to 5.1% of
the Company's total issued ordinary share capital.

The requisite notice in terms of section 122(3)(a) of the Companies Act has been filed with the Takeover
Regulation Panel.

The board of the Company accepts responsibility for the information contained in this announcement
and confirms that, to the best of its knowledge and belief, such information accurately reflects the
information contained in the TRP 121.1 form received by the Company from Carl Andre Capital.


Johannesburg
26 September 2024

Sponsor
Valeo Capital (Pty) Limited




                                                                                                      2

Date: 26-09-2024 08:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.